Company NIBEC Co., Ltd.

Equities

A138610

KR7138610001

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Medical Devices

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
17,430 ^KRW	+1.40%		-0.11%	-19.49%

2022	NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors	CI
2022	NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors	CI

NIBEC Co., Ltd. is a Korea-based company specialized in the manufacturing of dental medical products and supplies. The Company provides two main categories of products: dental health products and regeneration biomaterials. The dental health products consist of tooth whitening products under the brand name Blanc Tis; remedies for sensitive teeth under the brand name SensBlok, and dental conditioners under the brand name Clinplant. The regeneration biomaterials include bone graft materials under the brand name OCS-B, OCS-H and OCS-Collagen, as well as bone regenerative powders, bone morphogenetic materials, peptide bone powders and injectable gels. It also provides cosmetics under the brand name Skin Aropa. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 35

KRW in Million	2022	Weight	2023	Weight	Delta
Tissue Regeneration Biomaterial 96.3 %	21,614	99.7 %	15,118	96.3 %	-30.06%
Oral Health 2.0 %	-	-	310	2.0 %	-
Other 1.8 %	56	0.3 %	276	1.8 %	+390.32%

KRW in Million	2022	Weight	2023	Weight	Delta
Overseas 75.3 %	18,250	84.2 %	11,817	75.3 %	-35.25%
South Korea 24.7 %	3,420	15.8 %	3,887	24.7 %	+13.63%

Managers	Title	Age	Since
Jong-Pyeong Jeong CEO	Chief Executive Officer	78	-
Joo-Yeon Lee BRD	Director/Board Member	49	-
Yoon-Jeong Park BRD	Director/Board Member	53	-
Yang-Jo Seol AUD	Comptroller/Controller/Auditor	55	-

Members of the board	Title	Age	Since
Jong-Pyeong Jeong CEO	Chief Executive Officer	78	-
Yoon-Jeong Park BRD	Director/Board Member	53	-
Joo-Yeon Lee BRD	Director/Board Member	49	-
Sa-Seong Kim BRD	Director/Board Member	58	-
Won-Hee Cho BRD	Director/Board Member	54	-
Won-Bok Lee BRD	Director/Board Member	54	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,230,743	8,041,697 ( 78.60 %)	0	78.60 %

Name	Equities	%	Valuation
Jong-Pyeong Jeong 16.86 %	1,725,403	16.86 %	24 M ₩
Yoon-Jeong Park 3.596 %	367,928	3.596 %	5 M ₩
Joo-Yeon Lee 0.5612 %	57,412	0.5612 %	793 213 ₩
Sa-Seong Kim 0.1910 %	19,545	0.1910 %	270 037 ₩
Jeong-bin Kim 0.0977 %	10,000	0.0977 %	138 162 ₩

NIBEC Co., Ltd.

116 Bamdi-gil Iwol-myeon

27816, Jincheon-gun

http://www.nibec.co.kr

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Medical Devices

	1st Jan change	Capi.
NIBEC CO., LTD.	-19.49%	128M
MIMEDX GROUP, INC.	-28.62%	925M
COLLPLANT BIOTECHNOLOGIES LTD.	-6.57%	67.46M
KIM FOREST ENTERPRISE CO., LTD.	+5.69%	60.58M
BONUS BIOGROUP LTD.	+0.60%	51.45M

Bio Medical Devices